| 23.12.2024 XGEN Venture closes €180M life sciences fund |
| Bailey McCann, Opalesque New York: XGEN Venture, a leading venture capital firm specializing in life sciences investments, has closed its latest life sciences fund on €180M. The fund focuses on early-stage investments across biotechnology, medical devices, and diagnostics. XGEN Venture has already begun deploying capital in six startups, just recently adding iOnctura B.V.- a compan |